George B. Abercrombie is on the board of BioCryst Pharmaceuticals, Inc. (former Chairman), Physicians Interactive Holdings LLC, North Carolina Glaxosmithkline Foundation and Hessian Pharmaceuticals, Inc. and Member of North Carolina Board of Science & Technology and Adjunct Professor at The Fuqua School of Business.

He previously held the position of Principal at Merck & Co., Inc., President & CEO-Pharmaceuticals Operations at Roche Holding AG President & Chief Executive Officer of Hoffmann-La Roche, Inc. and President & Chief Executive Officer for Roche Laboratories, Inc. (both are subsidiaries of Roche Holding AG), Chief Commercial Officer & Senior Vice President at Innoviva, Inc., Director at Brickell Subsidiary, Inc. and Vice President & GM-Glaxo Pharmaceuticals at Glaxo Wellcome, Inc.

Mr. Abercrombie received an undergraduate degree from The University of North Carolina at Chapel Hill and an MBA from Harvard University.